{"title":"更正:中国老年人肝胆胰癌的风险预测:东风-同济队列。","authors":"","doi":"10.1111/jebm.12580","DOIUrl":null,"url":null,"abstract":"<p>Lyu J, Guan X, Zhou Y, Guo H, Cheng S, Wang C. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng-Tongji cohort. J Evid Based Med. 2023; 16:39-49.</p><p>1. In Supplementary Figure l, the unit in “Diagnosis of pancreatic or hepatobiliary cancer in < 3 or > 70 weeks of follow-up” was incorrect. The unit “weeks” should be changed to “months.”</p><p>2. In the second last paragraph of the Results section, the text “and even lower for PC (0.21%, 95% CI (0.13%, 0.28%)) and PPV (67.63%, 95% CI (67.19%, 68.07%) specificity, Table 3)” should be modified to “and even lower for PC (0.21% (0.13-0.28%) PPV and 67.63% (67.19-68.07%) specificity, Table 3).”</p><p>3. In the second paragraph of the Discussion section, three numbers of AUC were incorrect. The number 0.828 on line 6 should be 0.818. The number 0.862 on line 12 should be 0.843. The number 0.890 on line 13 should be 0.873.</p><p>We apologize for these errors, which were introduced unintentionally during the revision (1 and 3) and the production process (2). The correction does not change any results and conclusions of the article.</p>","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":"17 1","pages":"235"},"PeriodicalIF":3.6000,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jebm.12580","citationCount":"0","resultStr":"{\"title\":\"Correction to: Risk prediction of hepatobiliary and pancreatic cancersin elderly Chinese: The Dongfeng-Tongji cohort\",\"authors\":\"\",\"doi\":\"10.1111/jebm.12580\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Lyu J, Guan X, Zhou Y, Guo H, Cheng S, Wang C. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng-Tongji cohort. J Evid Based Med. 2023; 16:39-49.</p><p>1. In Supplementary Figure l, the unit in “Diagnosis of pancreatic or hepatobiliary cancer in < 3 or > 70 weeks of follow-up” was incorrect. The unit “weeks” should be changed to “months.”</p><p>2. In the second last paragraph of the Results section, the text “and even lower for PC (0.21%, 95% CI (0.13%, 0.28%)) and PPV (67.63%, 95% CI (67.19%, 68.07%) specificity, Table 3)” should be modified to “and even lower for PC (0.21% (0.13-0.28%) PPV and 67.63% (67.19-68.07%) specificity, Table 3).”</p><p>3. In the second paragraph of the Discussion section, three numbers of AUC were incorrect. The number 0.828 on line 6 should be 0.818. The number 0.862 on line 12 should be 0.843. The number 0.890 on line 13 should be 0.873.</p><p>We apologize for these errors, which were introduced unintentionally during the revision (1 and 3) and the production process (2). The correction does not change any results and conclusions of the article.</p>\",\"PeriodicalId\":16090,\"journal\":{\"name\":\"Journal of Evidence‐Based Medicine\",\"volume\":\"17 1\",\"pages\":\"235\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jebm.12580\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Evidence‐Based Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jebm.12580\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Evidence‐Based Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jebm.12580","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
Lyu J, Guan X, Zhou Y, Guo H, Cheng S, Wang C. 中国老年人肝胆胰癌的风险预测:东风-同济队列。J Evid Based Med.2023; 16:39-49.1.在补充图l中,"随访3周或70周诊断为胰腺癌或肝胆癌 "中的单位不正确。单位 "周 "应改为 "月"。结果部分倒数第二段中,"PC(0.21%,95% CI (0.13%, 0.28%))和 PPV(67.63%,95% CI (67.19%, 68.07%) 特异性,表 3)"应改为 "PC(0.21%,95% CI (0.13%, 0.28%))和 PPV(67.63%,95% CI (67.19%, 68.07%) 特异性,表 3)"。21% (0.13-0.28%) PPV 和 67.63% (67.19-68.07%) 特异性,表 3)"。 3.讨论部分第二段中,AUC 的三个数字不正确。第 6 行的数字 0.828 应为 0.818。第 12 行的数字 0.862 应为 0.843。第 13 行的数字 0.890 应为 0.873。我们对这些错误表示歉意,这些错误是在修订(1 和 3)和生产过程(2)中无意引入的。更正并不改变文章的任何结果和结论。
Correction to: Risk prediction of hepatobiliary and pancreatic cancersin elderly Chinese: The Dongfeng-Tongji cohort
Lyu J, Guan X, Zhou Y, Guo H, Cheng S, Wang C. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng-Tongji cohort. J Evid Based Med. 2023; 16:39-49.
1. In Supplementary Figure l, the unit in “Diagnosis of pancreatic or hepatobiliary cancer in < 3 or > 70 weeks of follow-up” was incorrect. The unit “weeks” should be changed to “months.”
2. In the second last paragraph of the Results section, the text “and even lower for PC (0.21%, 95% CI (0.13%, 0.28%)) and PPV (67.63%, 95% CI (67.19%, 68.07%) specificity, Table 3)” should be modified to “and even lower for PC (0.21% (0.13-0.28%) PPV and 67.63% (67.19-68.07%) specificity, Table 3).”
3. In the second paragraph of the Discussion section, three numbers of AUC were incorrect. The number 0.828 on line 6 should be 0.818. The number 0.862 on line 12 should be 0.843. The number 0.890 on line 13 should be 0.873.
We apologize for these errors, which were introduced unintentionally during the revision (1 and 3) and the production process (2). The correction does not change any results and conclusions of the article.
期刊介绍:
The Journal of Evidence-Based Medicine (EMB) is an esteemed international healthcare and medical decision-making journal, dedicated to publishing groundbreaking research outcomes in evidence-based decision-making, research, practice, and education. Serving as the official English-language journal of the Cochrane China Centre and West China Hospital of Sichuan University, we eagerly welcome editorials, commentaries, and systematic reviews encompassing various topics such as clinical trials, policy, drug and patient safety, education, and knowledge translation.